Peptide directorySkin, immune & repair

Agouti signalling protein

The skin’s switch from dark pigment to yellow, by blocking a melanocortin receptor.

Where it comes from

Made in
Dermal cells beneath hair follicles; in people, skin, fat tissue and testis
Sent out by
In a pulse during the hair cycle in mice, which gives the banded agouti hair; steadier in people
Acts on
  • Melanocytes (pigment type)
  • Fat tissue
  • Hypothalamus, in the mutant mouse only

What it does

  • Turns melanocytes from making black-brown eumelanin to red-yellow pheomelanin
  • Shapes the agouti coat of wild mice and the pattern of many mammals
  • In the yellow obese mouse, which expresses it everywhere, it blocks MC4R in the brain and causes obesity

In medicine

  • No medicine of its own; it is pigment genetics that brings it up in people
  • Variants near ASIP are associated with red hair and freckling 3, and with a raised risk of melanoma and basal cell carcinoma in Europeans 2

Beyond the body’s own use

  • Not a treatment and not in trials. The receptors it blocks are the drug targets instead: setmelanotide at MC4R and afamelanotide at MC1R push the signal the other way
  • What it does in adult people is still open: it is made in skin, fat and testis, while the pulse that bands a mouse’s hair has no human counterpart 1

Sources

  1. Lu et al., Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor, Nature 1994
  2. Gudbjartsson et al., ASIP and TYR pigmentation variants associate with cutaneous melanoma, Nature Genetics 2008
  3. Sulem et al., Two newly identified genetic determinants of pigmentation in Europeans, Nature Genetics 2008

This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.